Pfizer RSV vaccine Abrysvo safe in late pregnancy, interim data show
Interim safety data from Pfizer's RSV vaccine Abrysvo reveal no increased risks for pregnant women or their babies. Researchers reported the findings in JAMA after analyzing over 13,000 U.S. pregnancies.